The core of NCI-MATCH involves genomic profiling of a patient's tumor to identify specific genetic mutations or abnormalities. Once these genetic anomalies are identified, patients are matched with targeted therapies intended to address those specific mutations. The trial includes numerous sub-studies, each testing different targeted therapies based on the genetic characteristics of the tumors.
